Literature DB >> 30107011

Preoperative evaluation for epilepsy surgery: Process improvement.

Cornelia Drees1, Stefan Sillau1, Mesha-Gay Brown1, Aviva Abosch1.   

Abstract

BACKGROUND: Epilepsy surgery (ES) can improve seizure outcome. A prolonged duration of presurgical evaluation contributes to epilepsy-related morbidity and mortality. We introduced process changes to decrease evaluation time (ET) and increase ES numbers (excluding vagus nerve stimulation).
METHODS: The University of Colorado Hospital patient database was searched for ESs between January 2009 and May 2016. Measures to reduce ET included (1) increasing patient care conference (PCC) frequency; (2) faster intracarotid amobarbital test (IAT) scheduling; (3) dedicated ES clinic; and (4) adding a nurse navigator. ET from noninvasive video-EEG monitoring (P1) to IAT, PCC, and ES, and ES volume were determined and compared for a baseline group (P1 January 2009-March 2013) and a group exposed to process changes (P1 after March 2013), the postchanges group, to assess the effect of these measures.
RESULTS: ES number was 61 for the baseline group and 77 for the postchanges group, increasing the annual rate at 3 years after changes from 14.4 to 36.8 (p = 0.0008; 37% yearly increase postchanges). Interventions lowered average ET by 96 days (p ≤ 0.0001), P1 to IAT by 39 days (p = 0.0011), and P1 to PCC by 58 days (p = 0.0002).
CONCLUSIONS: Simple process changes, including more frequent patient care conferences, faster scheduling, a dedicated ES clinic, and a nurse navigator significantly decreased evaluation times and increased ES numbers. Centers could utilize similar strategies to improve process and surgical volume and thereby increase patient seizure control and safety.

Entities:  

Year:  2017        PMID: 30107011      PMCID: PMC6081968          DOI: 10.1212/CPJ.0000000000000357

Source DB:  PubMed          Journal:  Neurol Clin Pract        ISSN: 2163-0402


  13 in total

1.  Early surgical therapy for drug-resistant temporal lobe epilepsy: a randomized trial.

Authors:  Jerome Engel; Michael P McDermott; Samuel Wiebe; John T Langfitt; John M Stern; Sandra Dewar; Michael R Sperling; Irenita Gardiner; Giuseppe Erba; Itzhak Fried; Margaret Jacobs; Harry V Vinters; Scott Mintzer; Karl Kieburtz
Journal:  JAMA       Date:  2012-03-07       Impact factor: 56.272

2.  Essential services, personnel, and facilities in specialized epilepsy centers--revised 2010 guidelines.

Authors:  David M Labiner; Anto I Bagic; Susan T Herman; Nathan B Fountain; Thaddeus S Walczak; Robert J Gumnit
Journal:  Epilepsia       Date:  2010-11       Impact factor: 5.864

3.  Early identification of refractory epilepsy.

Authors:  P Kwan; M J Brodie
Journal:  N Engl J Med       Date:  2000-02-03       Impact factor: 91.245

4.  A randomized, controlled trial of surgery for temporal-lobe epilepsy.

Authors:  S Wiebe; W T Blume; J P Girvin; M Eliasziw
Journal:  N Engl J Med       Date:  2001-08-02       Impact factor: 91.245

5.  Attitudes towards epilepsy surgery: A nationwide survey among Swedish neurologists.

Authors:  Eva Kumlien; Peter Mattsson
Journal:  Seizure       Date:  2010-03-12       Impact factor: 3.184

6.  Socioeconomic status, health care use, and outcomes: persistence of disparities over time.

Authors:  Charles Begley; Rituparna Basu; David Lairson; Thomas Reynolds; Stephanie Dubinsky; Michael Newmark; Forbes Barnwell; Allen Hauser; Dale Hesdorffer
Journal:  Epilepsia       Date:  2011-02-14       Impact factor: 5.864

7.  Acceptance of epilepsy surgery among adults with epilepsy--what do patients think?

Authors:  Giuseppe Erba; Paolo Messina; Elisabetta Pupillo; Ettore Beghi
Journal:  Epilepsy Behav       Date:  2012-05-30       Impact factor: 2.937

8.  Knowledge and Attitudes About Epilepsy Surgery Among Family Doctors in Ontario.

Authors:  Nicholas Cothros; Jorge G Burneo; David A Steven
Journal:  Can J Neurol Sci       Date:  2016-09       Impact factor: 2.104

9.  A survey of neurologists' views on epilepsy surgery and medically refractory epilepsy.

Authors:  Andrea S Hakimi; Marianna V Spanaki; Lori A Schuh; Brien J Smith; Lonni Schultz
Journal:  Epilepsy Behav       Date:  2008-03-11       Impact factor: 2.937

10.  Disparities in surgery among patients with intractable epilepsy in a universal health system.

Authors:  Jorge G Burneo; Salimah Z Shariff; Kuan Liu; Sean Leonard; Gustavo Saposnik; Amit X Garg
Journal:  Neurology       Date:  2015-12-07       Impact factor: 9.910

View more
  5 in total

1.  Addressing barriers to surgical evaluation for patients with epilepsy.

Authors:  Chloe E Hill; Jackie Raab; Delight Roberts; Timothy Lucas; John Pollard; Ammar Kheder; Brian Litt; Kathryn A Davis
Journal:  Epilepsy Behav       Date:  2018-07-19       Impact factor: 2.937

2.  Epilepsy, dissociative seizures, and mixed: Associations with time to video-EEG.

Authors:  Wesley T Kerr; Xingruo Zhang; Chloe E Hill; Emily A Janio; Andrea M Chau; Chelsea T Braesch; Justine M Le; Jessica M Hori; Akash B Patel; Corinne H Allas; Amir H Karimi; Ishita Dubey; Siddhika S Sreenivasan; Norma L Gallardo; Janar Bauirjan; Eric S Hwang; Emily C Davis; Shannon R D'Ambrosio; Mona Al Banna; Andrew Y Cho; Sandra R Dewar; Jerome Engel; Jamie D Feusner; John M Stern
Journal:  Seizure       Date:  2021-02-09       Impact factor: 3.184

3.  Addressing the epilepsy surgery gap: Impact of community/tertiary epilepsy center collaboration.

Authors:  Keyan Peterson; Suzette LaRoche; Tiffany Cummings; Valerie Woodard; Anna-Marieta Moise; Heidi Munger Clary
Journal:  Epilepsy Behav Rep       Date:  2020-10-29

Review 4.  Underutilization of epilepsy surgery: Part I: A scoping review of barriers.

Authors:  Debopam Samanta; Adam P Ostendorf; Erin Willis; Rani Singh; Satyanarayana Gedela; Ravindra Arya; M Scott Perry
Journal:  Epilepsy Behav       Date:  2021-02-18       Impact factor: 2.937

Review 5.  Underutilization of epilepsy surgery: Part II: Strategies to overcome barriers.

Authors:  Debopam Samanta; Rani Singh; Satyanarayana Gedela; M Scott Perry; Ravindra Arya
Journal:  Epilepsy Behav       Date:  2021-03-04       Impact factor: 2.937

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.